Reset filter
Mots-clés
Afficher plus Mots-clés
Table des matières
  1. 1. Essai clinique
  2. 2. Routinedokumentation
  3. 3. Études de registres/cohortes
  4. 4. Assurance qualité
  5. 5. Standard de données
  6. 6. Questionnaire pour les patients
  7. 7. Spécialité médicale
    1. 7.1. Anesthésie
    1. 7.2. Dermatologie
    1. 7.3. HNO
    1. 7.4. Gériatrie
    1. 7.5. Gynécologie/obstétrique
    1. 7.6. Médecine interne
      1. Hématologie
      1. Infectiologie
      1. Cardiologie/angiologie
      1. Pneumologie
      1. Gastroentérologie
      1. Néphrologie
      1. Endocrinologie/métabolisme
      1. Rhumatologie
    1. 7.7. Neurologie
    1. 7.8. Ophtalmologie
    1. 7.9. Médecine palliative
    1. 7.10. Pathologie/médécine légale
    1. 7.11. Pédiatrie
    1. 7.12. Psychiatrie/psychosomatique
    1. 7.13. Radiologie
    1. 7.14. Chirurgie
      1. Chirurgie générale/viscérale
      1. Neurochirurgie
      1. Chirurgie plastique
      1. Chirurgie cardiaque/thoracique
      1. Chirurgie traumatologique/orthopédie
      1. Chirurgie vasculaire
    1. 7.15. Urologie
    1. 7.16. Médecine dentaire/MKG
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

99 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Checklist for genetic disposition breast cancer and/or Ovarian cancer

- 30/07/2015 - 1 Formulaire, 6 Groupes Item, 32 Eléments de données, 2 Langues
Groupes Item: Patient demographics, A. Patient and her siblings / children, B. Matrilineality, C. Patrilineality, D. Higher score B. matrilineality or C. patrilineality, E. Total A+D
ODM form derived from Humangenetik Senologie UKM. Used as a routine documentation by the University Hospital Muenster, Germany.

Quality Assurance Checklist For Potential Genetic Liability By Breast Cancer and Ovarian Cancer - Checklist

- 26/06/2016 - 1 Formulaire, 4 Groupes Item, 79 Eléments de données, 1 Langue
Groupes Item: Patient information, Hereditary factor Siblings children, Hereditary factor Maternal Relative, Hereditary factor Paternal Relative
Documentation form for quality assurance in German Health Care by the Aerztekammer Wesfalen-Lippe, http://www.aekwl.de/index.php?id=1788, Form version 30. März 2016 (C)

Cancer: Personal and Family History Protocol PhenX Toolkit

- 20/09/2021 - 1 Formulaire, 1 Groupe Item, 9 Eléments de données, 1 Langue
Groupe Item: PhenX - cancer - personal and family history protocol
This protocol is used to assess if the respondent and his or her biological parents, siblings, and children have had cancer. This protocol also obtains information about vital status, age, type of cancer, age at first diagnosis, and any additional cancer diagnoses. ODM derived from: https://cde.nlm.nih.gov Primary source: https://www.phenxtoolkit.org/ Recent publication: Hendershot, T., Pan, H., Haines, J., Harlan, W.R., Marazita, M.L., McCarty, C.A., Ramos, E.M., and Hamilton, C.M. (2015) Using the PhenX toolkit to add standard measures to a study. Curr. Protoc. Hum. Genet. 86:1.21.1-1.21.17. doi: 10.1002/0471142905.hg0121s86 Permission to publish granted by Carol M. Hamilton.

dbGaP phs001134 Radiation-related Genomic Profile of Papillary Thyroid Cancer after the Chernobyl Accident - pht011228.v1.p1

- 16/06/2023 - 6 Formulaires, 1 Groupe Item, 5 Eléments de données, 1 Langue
Groupe Item: pht011228
Principal Investigator: Chanock SJ, MD, National Cancer Institute, Bethesda, MD, USA MeSH: Thyroid Cancer, Papillary,Chernobyl Nuclear Accident,Neoplasms, Radiation-Induced,Iodine Radioisotopes https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001134 The April 26, 1986 accident at the Chernobyl nuclear power plant in northern Ukraine resulted in the release of radioactive contaminants, which were deposited in the surrounding areas in Ukraine, Belarus, and Russia. The main radiation-related health effect resulting from these exposures is the increased occurrence of thyroid cancer among individuals who were children at the time of the accident or born shortly thereafter. The purpose of this study was to conduct a comprehensive genomic landscape analysis of papillary thyroid tumors arising in individuals who were exposed as children to radioactive iodine (I-131) from the Chernobyl nuclear power plant accident.

Eligibility

1 Groupe Item 6 Eléments de données

pht011224.v1.p1

1 Groupe Item 3 Eléments de données

pht011225.v1.p1

1 Groupe Item 6 Eléments de données

pht011226.v1.p1

1 Groupe Item 2 Eléments de données

pht011227.v1.p1

1 Groupe Item 7 Eléments de données

dbGaP phs000543 Exome Sequencing of Pleuropulmonary Blastoma - pht002936.v1.p1

- 19/11/2022 - 4 Formulaires, 1 Groupe Item, 2 Eléments de données, 1 Langue
Groupe Item: pht002936
Principal Investigator: Ashley Hill, MD, Children's National Medical Center, Washington, DC, USA MeSH: Pleuropulmonary blastoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000543 Pleuropulmonary blastoma (PPB) is a rare, aggressive pediatric cancer arising from the lung or pleural cavity. In this study, we sequenced and analyzed the exomes of 15 PPB matched tumor and normal pairs. This study is part of a larger effort to characterize pediatric cancers as part of the Slim Initiative for Genomic Medicine (SIGMA) project.

pht002937.v1.p1

1 Groupe Item 3 Eléments de données

pht002939.v1.p1

1 Groupe Item 5 Eléments de données

pht002938.v1.p1

1 Groupe Item 4 Eléments de données

dbGaP phs000352 Sequencing of Retinoblastoma - pht002287.v1.p1

- 12/10/2022 - 6 Formulaires, 1 Groupe Item, 7 Eléments de données, 1 Langue
Groupe Item: pht002287
Principal Investigator: Michael A. Dyer, PhD, Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA MeSH: Retinoblastoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000352 Retinoblastoma is a pediatric cancer of the developing retina. All retinoblastomas are believed to initiate with biallelic inactivation of the RB1 gene. To identify subsequent genetic lesions in retinoblastoma, we performed whole genome sequencing of tumor and normal DNA of 4 children with retinoblastoma and one matched orthotopic xenograft. Both alleles of RB1 were inactivated in the tumor samples. 3 of the patients had sporadic retinoblastoma and one patient had inherited retinoblastoma. Overall, there were few single nucleotide changes in coding regions of the genome and some of the tumors had few chromosomal lesions. There were very few new genetic lesions in the xenograft compared to the primary tumor. These data suggest that the genome in retinoblastoma is more stable than previously believed and there are relatively few recurrent genetic lesions in known cancer pathways other than the RB1 pathway.

pht002354.v1.p1

1 Groupe Item 2 Eléments de données

Eligibility

1 Groupe Item 1 Élément de données

pht002284.v1.p1

1 Groupe Item 5 Eléments de données

pht002285.v1.p1

1 Groupe Item 4 Eléments de données

pht002286.v1.p1

1 Groupe Item 16 Eléments de données

dbGaP phs000828 Genomic Analysis of Hepatocellular Carcinoma - Eligibility

- 04/03/2024 - 4 Formulaires, 1 Groupe Item, 5 Eléments de données, 1 Langue
Groupe Item: IG.elig
Principal Investigator: Julien Sage, PhD, Departments of Pediatrics and Genetics, Stanford University, Stanford, CA, USA MeSH: Fibrolamellar hepatocellular carcinoma,Carcinoma, Hepatocellular https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000828 Fibrolamellar hepatocellular carcinoma (FL-HCC) is a very rare and distinct subtype of hepatocellular carcinoma that occurs in the previously healthy livers of adolescents and young adults. The low incidence rate has kept FL-HCC an understudied cancer, thus the list of FL-HCC markers is limited and the genetic alterations driving its growth have remained unknown. In order to gain a better understanding of the molecular mechanisms underlying FL-HCC initiation and progression, we performed an in-depth genomic analyses of one tumor followed by immunohistochemistry validation on seven other tumors. We showed the expression of neuroendocrine markers in FL-HCC. In addition, DNA/RNA sequencing revealed that common cancer pathways are not visibly altered in FL-HCC but identified two novel structural variants, both resulting in fusion transcripts. Through in vitro studies, we demonstrated the oncogenic properties of these fusion transcripts. These experiments further highlight the tumorigenic role of gene fusions in the etiology of pediatric solid tumors and identify both candidate biomarkers and possible therapeutic targets for this lethal pediatric disease.

pht004327.v1.p1

1 Groupe Item 3 Eléments de données

pht004328.v1.p1

1 Groupe Item 3 Eléments de données

pht004329.v1.p1

1 Groupe Item 8 Eléments de données

SIOP CNS GCT II DRKS00003907 NCT01424839 - Toxicity during chemotherapy course NCT01424839

- 06/06/2015 - 1 Formulaire, 10 Groupes Item, 39 Eléments de données, 2 Langues
Groupes Item: Toxicity hematology, Toxicity neurological, Toxicity infection, Toxicity gastrointestinal, Toxicity skin, Toxicity renal, Toxicity Hearing, Toxicity cardiac, Toxicity metabolic/laboratory, Toxicity other
SIOP CNS GCT II: Prospective Trial for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Intracranial Germ Cell Tumors. Principal Investigator Gabriele Calaminus, MD. http://clinicaltrials.gov/show/NCT01424839

SIOP CNS GCT II Sites of tumour and metastases DRKS00003907 - Sites of tumour and metastases

- 19/09/2014 - 1 Formulaire, 4 Groupes Item, 18 Eléments de données, 2 Langues
Groupes Item: Show identification of patient, Primary tumour at registration, Metastases at registration, Site of tumour summarised
SIOP CNS GCT II: Prospective Trial for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Intracranial Germ Cell Tumors. Principal Investigator Gabriele Calaminus, MD. http://clinicaltrials.gov/show/NCT01424839

SIOP CNS GCT II Tumour components DRKS00003907 - Tumour components

- 19/09/2014 - 1 Formulaire, 3 Groupes Item, 13 Eléments de données, 2 Langues
Groupes Item: Show identification of patient, Tumour components at registration, Tumour diagnosis group
SIOP CNS GCT II: Prospective Trial for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Intracranial Germ Cell Tumors. Principal Investigator Gabriele Calaminus, MD. http://clinicaltrials.gov/show/NCT01424839

SIOP CNS GCT II Study centre DRKS00003907 - Study centre

- 19/09/2014 - 1 Formulaire, 7 Groupes Item, 23 Eléments de données, 2 Langues
Groupes Item: Show identification of patient, Study centre data on registration, Study centre data on chemotherapy, Study centre data on radiotherapy, Study centre data on end of therapy, Study centre data on surgery, Study centre data on histology
SIOP CNS GCT II: Prospective Trial for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Intracranial Germ Cell Tumors. Principal Investigator Gabriele Calaminus, MD. http://clinicaltrials.gov/show/NCT01424839

SIOP CNS GCT II Registration data SIOP CNS GCT II DRKS00003907 - Registration data SIOP CNS GCT II

- 19/09/2014 - 1 Formulaire, 5 Groupes Item, 22 Eléments de données, 2 Langues
Groupes Item: Show identification of patient, Registration data SIOP CNS GCT II, Inclusion criteria, Demographic data, Exclusion criteria
SIOP CNS GCT II: Prospective Trial for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Intracranial Germ Cell Tumors. Principal Investigator Gabriele Calaminus, MD. http://clinicaltrials.gov/show/NCT01424839

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial